We previously reported that human granulosa cells (GC) express integrin α 6 β 1 in large follicles and early corpus luteum (CL). In this study, we examined the expression of integrin α 5 and fibronectin (FN) by immunohistochemistry. Integrin α 5 was undetectable on human GC in preovulatory follicles, but it was intensely expressed on luteinizing GC of CL in the early luteal phase, and it was weakly expressed on large luteal cells (LL) in the midluteal phase. FN was similarly expressed between GC/LL. Thus, integrin α 5 and FN were stage-specifically expressed on/between luteinizing GC in the early luteal phase. Next we examined the effect of human chorionic gonadotrophin (HCG) on expression of integrin α 5 on luteinizing GC in vitro. GC obtained from preovulatory follicles were cultured for 3 days without (control) or with HCG (1 IU/ml), and expression of integrin α 5 was examined by flow cytometry. Although the positivity rate did not differ, the mean relative fluorescence intensity was 3.4-fold higher in the HCG-treated group (n ϭ 8, P Ͻ 0.01). These findings indicate that integrin α 5 is rapidly expressed on GC during luteinization, probably under LH stimulation, and suggest that integrin α 5 is involved in CL formation via interaction with its ligand FN.
Introduction
To investigate the regulatory factors involved in ovarian cell differentiation, we raised monoclonal antibodies (mAb) against human or porcine ovarian cells, and reported that ovarian cells express several cell surface molecules in a differentiation stage-and/or cell lineage-specific manner (Fujiwara et al., 1992a (Fujiwara et al., , 1992b (Fujiwara et al., , 1993a (Fujiwara et al., , 1996a Hattori et al., 1995) . Of these molecules, we showed that membrane-bound aminopeptidases play a role in follicular growth by regulating differentiation and functions of the ovarian cells (Tachibana et al., 1996; Nakamura et al., 1996) .
Using the mAb, named OG-1, raised against human granulosa cells (GC), we similarly identified a cell surface molecule which is highly expressed on GC during the periovulatory phase (Fujiwara et al., 1993b) . Later, we showed that OG-1 antigen is identical to integrin α 6 by analysing N-terminal amino acid sequences of the purified OG-1 antigen. We also demonstrated that human GC express integrin β 1 , but not integrin β 4 , indicating that integrin α 6 expressed on GC forms a heterodimer with β 1 , but not with β 4 (Honda et al., 1995) . Furthermore, we raised the mAb POG-2 against porcine GC, and demonstrated that POG-2 antigen is a porcine homologue of integrin α 6 by N-terminal amino acid sequencing . In the porcine ovary, integrin α 6 was expressed on GC in the small follicles (1-2 mm in diameter) with maximal immunoreactivity, and was undetectable in corpora lutea (CL). These stage-specific expression profiles suggested the involvement of integrin α 6 in ovarian physiology (Fujiwara et al., 1996b) . Since the ligand for integrin α 6 β 1 is laminin (LN) (Sonnenberg et al., 1988) , we examined the expression of LN on GC, and the physiological function of the interaction between integrin α 6 β 1 and LN during CL formation, and showed that LN suppresses GC luteinization via integrin α 6 β 1 (Fujiwara et al., 1997) . This finding supported the notion that stage-specifically expressed molecules provide a clue to the regulatory factors involved in ovarian physiology.
Since integrin β 1 was expressed more widely in human ovarian cells than integrin α 6 (Honda et al., 1995) , the expression of other member(s) of the integrin β 1 family was suggested. In the present study, we examined the expression of integrin α 5 in human preovulatory follicles and CL of the menstrual cycle and early pregnancy, and found that integrin α 5 was expressed on GC during CL formation. We also examined the expression of fibronectin (FN), the ligand for integrin α 5 β 1 (Hynes, 1992; Haas and Plow, 1994) .
Materials and methods

Antibodies
The murine anti-human integrin α 5 mAb, SAM-1 (IgG1 isotype) and P1D6 (IgG3) (Wayner et al., 1988) were purchased from Serotec (Oxford, UK) and Gibco BRL (Gaithersburg, MD, USA), respectively. The murine anti-FN (2B6-F9, IgG1) was purchased from Cedarlane, Ontario, Canada. The murine anti-trinitrophenyl (TNP) mAb (IgG1) (Tsujimura et al., 1990) and purified mouse IgG3 (FLOPC-21, Cedarlane) were used as negative controls.
Human ovaries
Preovulatory follicles (n ϭ 4) and CL of the menstrual cycle (n ϭ 18) were obtained from 22 patients, aged 30-45 years, who had regular menstrual cycles and underwent surgery for benign gynaecological disease. CL of pregnancy, ranging from 6 to 15 weeks, were obtained from five pregnant patients who underwent hysterectomy for the treatment of cervical carcinoma in situ or uterine myoma. The fetal growth of all five patients was normal on ultrasonographical examination. Written informed consent was obtained from each patient.
Follicles were morphologically evaluated by staining cryosections with haematoxylin and eosin (HE). Follicles obtained in the follicular phase, 18-20 mm in diameter, with GC having mitotic figures and regularly shaped nuclei, cytoplasm, and stratified layers were classified as preovulatory growing follicles (Ryan, 1981) . The postovulatory stage of CL was evaluated according to the histological dating described by Corner (1956) , using HE-stained tissue sections of 10% formalin-fixed and paraffin-embedded samples. In this work, the term 'CL day' was used according to his definition. For example, CL day 2 is the day after ovulation.
Indirect immunohistochemical staining of frozen sections
Indirect immunofluorescence histochemistry proceeded as described (Fujiwara et al., 1993b) . Briefly, each specimen was embedded in OCT compound (Tissue-Tec, Miles Scientific, Naperville, IL, USA), snap-frozen in liquid nitrogen and stored at -80°C. Frozen tissues were sliced to 7 µm thickness using a cryostat microtome (Cryocut 1800; Reichert-Jung, Heidelberg, Germany), immediately air-dried on Neoprene (Nisshin EM, Tokyo, Japan)-coated glass slides and fixed in acetone at -20°C for 5 min. The slides were incubated with the anti-integrin α 5 or anti-FN or control mAb for 30 min at room temperature. The anti-α 5 mAb P1D6 was used at 1:500 dilution of ascites, and other mAb were used at a concentration of 5 µg/ml. After washing in phosphate-buffered saline (PBS), slides were incubated with the fluorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse immunoglobulin (Ig) antibody (diluted 1:40, Dakopatts A/S, Glostrup, Denmark) for 30 min at room temperature in the dark. The slides were washed, mounted with Perma Fluor Aqueous Mounting Medium (Immunon, Pittsburgh, PA, USA), and examined under a fluorescence microscope (Nikon, Tokyo, Japan). Serial cryosections were also stained with HE after fixation in 95% ethanol.
Isolation of human luteinizing GC
Human GC were isolated from 15 patients, aged from 27 to 40 years old, undergoing in-vitro fertilization (IVF) as described previously (Fujiwara et al., 1994) . Briefly, patients receiving a gonadotropin releasing hormone analogue (buserelin acetate; Hoechst Japan Co. Ltd, Tokyo, Japan) from the first day of the cycle, were hyperstimulated with human menopausal gonadotrophin (Organon Japan Co. Ltd, Tokyo, Japan) until the follicles reached maturity. Follicles were aspirated 36 h after the administration of HCG (Mochida Pharmaceutical Co. Ltd, Osaka, Japan). The follicular fluid was collected and centrifuged. The sedimented cells were resuspended, overlayered on Ficoll-Hypaque and centrifuged at 400 g for 30 min. The cells were collected from the interphase. In seven cases, the isolated GC were immediately analysed by flow cytometry. In the other cases, GC were cultured as described below.
Flow cytometrical analysis of human luteinizing GC Flow cytometry proceeded as described (Fujiwara et al., 1994) . The isolated human GC were washed in Hanks' balanced salt solution (HBSS) with 0.1% bovine serum albumin (BSA; Nitta Gelatin Corp., Osaka, Japan) and 0.1% NaN 3 , sedimented by centrifugation and 980 incubated with the anti-integrin α 5 (P1D6, ascites diluted at 1:10) or the purified mouse IgG3 (control, 100 µg/ml) for 30 min at 4°C. After washing with HBSS, the cell pellet was incubated with FITCconjugated rabbit anti-mouse Ig, for 30 min at 4°C in the dark. After washing in HBSS, the cells were resuspended in the same solution and viable cells were analysed by flow cytometry (FACScan; Becton Dickinson Immunocytometry Systems Japan, Tokyo, Japan). The ratio of contaminating monocytes, identified by the anti-CD14 mAb (Becton Dickinson, Lincoln Park, NJ, USA), was Ͻ3%.
Culture of human luteinizing GC
The isolated human GC, were suspended (5ϫ10 5 cells/4 ml) in Roswell Park Memorial Institute medium (RPMI) 1640 (ICN Biochemicals, Costa Mesa, CA, USA) with 10% fetal calf serum (FCS; Flow Laboratories, McLean, VA, USA), 100 µg/ml kanamycin sulphate (Meiji Seika, Tokyo, Japan), then cultured on six-well plates (Becton Dickinson) for 24 h. The following day (day 1), the medium was discarded to remove unattached cells and was replaced with serum-free Dulbecco's modified Eagle's medium/F12 (1:1, v/v, Gibco, Grand Island, NY, USA) medium with 0.2 % bovine serum albumin and 10 mM HEPES (Nacalai tesque, Kyoto, Japan), without (control) or with HCG (1 IU/ml). The cells were cultured for 3 days, during which the serum-free medium was exchanged and HCG was added every day. On day 4, the plates were gently washed with PBS to remove the unattached cells, then incubated with PBS with 0.05% trypsin (Difco, Detroit, MI, USA) and 0.05% EDTA (Nacalai tesque) for 5 min at room temperature. The reaction was stopped with Roswell Park Memorial Institute medium 1640 containing 10% FCS. The cells were washed in HBSS, and flow cytometrical analysis proceeded as described above.
In some cases, GC were seeded on 8-well glass slide chambers (LabTek, Nunc, Inc., Naperville, IL, USA), and cultured as above. On day 4, medium was discarded and the attached cells were air-dried. The slides were stained with anti-integrin α 5 mAb as described above.
Statistical analysis
In flow cytometrical analysis, the differences of positivity rate and mean fluorescence intensity of integrin α 5 expression on GC were analysed by the two-tailed paired t-test.
Results
Expression of integrin α 5 and FN in human ovary
In preovulatory follicles (18-20 mm in diameter, n ϭ 4), integrin α 5 was weakly expressed on vessels and stroma, but not detected on GC ( Figure 1B) . The two anti-α 5 mAb reacted in almost the same way. FN was detected on the basal lamina, around vessels and in stroma, but it was undetectable between GC ( Figure 1D ).
In CL of the early luteal phase (CL day 2-5, n ϭ 6), integrin α 5 was intensely expressed on luteinizing GC, weakly on luteinizing thecal cells, vessels and stromal cells ( Figure 1F ). FN was observed between luteinizing granulosa and thecal cells, around vessels and in stroma ( Figure 1H ).
In CL of the midluteal phase (CL days 6-10, n ϭ 7), integrin α 5 was weakly expressed on large luteal cells (LL), small luteal cells (SL), vessels and stromal cells ( Figure 2B ). FN was observed clearly around vessels and in stroma, and weakly expressed between LL and SL ( Figure 2D ).
In CL of the late luteal phase (CL days 11-14, n ϭ 5) and of early pregnancy (6-15 weeks of gestation, n ϭ 5), integrin α 5 was expressed on vessels, but almost undetectable on LL and SL. FN was observed around vessels and in stroma, but was not clearly detected between luteal cells (data not shown).
Expression of integrin α 5 on isolated GC
Flow cytometry showed that integrin α 5 was expressed on the cell surface of 46.4 Ϯ 17.3% (mean Ϯ SD, n ϭ 7) of freshly isolated GC from preovulatory follicles of patients undergoing IVF.
Effect of HCG on expression of integrin α 5 on cultured GC
By immunocytochemistry, integrin α 5 expression on cultured GC isolated from patients undergoing IVF was found to be higher in the HCG-treated group than in the control group (Figure 3) . By flow cytometry, integrin α 5 was found to be expressed on 79.4 Ϯ 10.4% and 74.3 Ϯ 14.1% of GC cultured with or without HCG respectively (mean Ϯ SD). On the other hand, the mean relative fluorescence intensity was 3.38 Ϯ 1.82-fold higher in the HCG-treated group (mean Ϯ SD, n ϭ 8, P Ͻ 0.01). A histogram of a typical case is shown in Figure 4 .
Discussion
Integrin α 5 was not detected on GC in preovulatory follicles by immunohistochemistry. In contrast, it was intensely 982 expressed on luteinizing GC on the next day of ovulation and continued to be clearly detected during CL formation. Flow cytometry showed that integrin α 5 was expressed on 46% of GC obtained from follicles just prior to ovulation. These findings indicate that GC start to express integrin α 5 just prior to ovulation and suggest that LH surge induces this expression. To examine the effect of LH on integrin α 5 expression, we cultured GC with or without HCG. Flow cytometry showed that integrin α 5 expression was enhanced by HCG in vitro. This result supports the involvement of LH surge in the induction of integrin α 5 expression before ovulation, and suggests that LH enhances or maintains integrin α 5 expression on luteinizing GC during CL formation.
After LH surge, GC start to luteinize and differentiate to LL. In this process, GC morphologically and functionally change and acquire the ability to produce abundant progesterone. Many cell surface molecules, which are involved in luteal cell function and differentiation, are presumed to appear on luteinizing GC during CL formation, but few have yet been identified. We have shown that LL express human leukocyte antigen (HLA)-DR, dipeptidyl peptidase IV (DPP-IV), and human corpus luteum antigen-1 (HCL-1) (Fujiwara et al., 1992b (Fujiwara et al., , 1993a (Fujiwara et al., , 1996a . Immunohistochemistry has demonstrated that these cell surface molecules are expressed on GC after ovulation and their expressions are augmented during CL formation in vivo, suggesting that they play a role in LL function and differentiation. During CL formation, their expressions are gradually augmented until they are highly expressed on CL Histograms of flow cytometry of cultured human luteinizing granulosa cells (GC), using the anti-integrin α 5 mAb P1D6 and the purified mouse IgG3 (negative control, N.C.). After preincubation in serum-containing medium for 24 h, human GC were cultured for 3 days in serum-free medium without (control), or with human chorionic gonadotrophin (HCG) (1 IU/ml). In the HCG-treated group, the integrin α 5 histogram showed that the mean fluorescence intensity was higher than in the control. day 4 or 5. In contrast to these molecules, integrin α 5 was rapidly expressed on luteinizing GC during ovulation. As far as we know, this is the first report of a cell surface molecule whose expression is rapidly induced on luteinizing GC during ovulation. It can be concluded that integrin α 5 is a cell surface marker of differentiation of GC at the initial step of luteinization.
Although the expression of integrin α 5 was intense in the early luteal phase, it weakened in LL, which are already fully luteinized, and was undetectable on luteal cells in late luteal and early pregnancy. Integrin α 5 subunit reportedly forms heterodimer only with β 1 subunit and we have reported that integrin β 1 is expressed on human GC during CL formation (Honda et al., 1995) . These expression profiles strongly suggest a specific physiological role for integrin α 5 β 1 on luteinizing GC during CL formation. Integrin α 5 β 1 is reported to be a receptor of FN (Hynes, 1992; Haas and Plow, 1994) . Therefore, we also examined the expression of FN in the follicles and CL. The expression profile of FN among GC and LL was similar to that of integrin α 5 . FN was not detected between GC in preovulatory follicles, but it was clearly detected between luteinizing GC in the early luteal phase. These findings indicate a possible interaction between integrin α 5 β 1 and FN during CL formation.
During ovulation and CL formation, the basal lamina of the follicle is destroyed, and the central cavity is replaced by cellular components, including luteinizing cells, vascular cells and white blood cells. The interaction between integrin α 5 β 1 and FN may have an important role in reconstruction of tissue integrity. On the other hand, there is accumulating evidence that the interaction between integrins and extracellular matrices is involved not only in cell adhesion but also in cell growth, differentiation and function (Hynes, 1992; Bronson and Fusi, 1996) . In ovarian physiology, extracellular matrices are reported to regulate GC differentiation (Amsterdam and Rotmensch, 1987) . FN stimulates rat GC growth (Morley et al., 1987) , and FN enhances bovine GC response to FSH (Saumande, 1991) . FN enhances FSH binding sites and progesterone production in immature porcine GC (Sites et al., 1996) . In human, FN enhances LH-stimulated progesterone production by cultured GC after preincubation for 7 days (Schipper et al., 1993) . Therefore, we speculate that integrin α 5 β 1 is involved in differentiation of luteinizing GC during CL formation via the interaction with FN.
